Carregant...
Nanomedicine as a strategy to fight thrombotic diseases
This review highlights the preclinical and clinical research based on the use of nano- and micro-carriers in thrombolytic drug delivery. Ischemic heart and stroke caused by thrombosis are the main causes of death in the world. Because of their inactivation in the blood, high doses of thrombolytics a...
Guardat en:
| Publicat a: | Future Sci OA |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Future Science Ltd
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5137979/ https://ncbi.nlm.nih.gov/pubmed/28031907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fso.15.46 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|